Eric Niespodzony, MD
Ophthalmology · Eugene, ORNPI 1245624782
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.9%), travel and lodging and gifts — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Biotissue Holdings Inc. at 36.0% of the total. Reporting peaked in 2022 at $2,883 and has fallen 66.0% since, to $981 in 2025. Among ophthalmology clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 135 payments — averaging $76.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$4K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$2K
- Glaukos Corporation$1K
- Alcon$982
- AbbVie$690
- Rxsight Inc$600
- plus $1K from 15 others
What the payments were for
- Travel & lodging$4,22841%
- Food & beverage$6,01758%
- Education$240%
- Gifts$1211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 12 | $3,742 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 22 | $2,023 |
| Glaukos Corporation | 22 | $1,069 |
| Alcon | 23 | $982 |
| AbbVie(2 entities) | 15 | $690 |
| Rxsight Inc | 7 | $600 |
| Johnson & Johnson Surgical Vision, Inc. | 10 | $536 |
| Beaver-visitec International, Inc. | 2 | $178 |
| Bausch & Lomb Americas Inc. | 4 | $174 |
| Sight Sciences, Inc. | 3 | $96 |
| Dompe US, Inc. | 3 | $68 |
| Amgen(2 entities) | 2 | $49 |
| Sun Pharmaceutical Industries Inc. | 2 | $36 |
| Leica Microsystems Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Aerie Pharmaceuticals, Inc. | 1 | $17 |
| Ivantis, Inc | 1 | $17 |
| Tarsus Pharmaceuticals, Inc. | 1 | $17 |
| Orthofix Medical, Inc. | 1 | $17 |
| Thea Pharma Inc. | 1 | $17 |
| NEW World Medical,inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prokera$3,556
- AmnioGraft$3,556
- ENVISTA$1,264
- OPHTHALMIC INSTRUMENTS$1,145
- TRULIGN TORIC$1,145
- CRYSTALENS$1,145
- RXSIGHT CONTACT LENS$317
- RXSIGHT INJECTOR CARTRIDGE$317
- RXSIGHT INJECTOR HANDPIECE$317
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$317
- LIGHT ADJUSTABLE LENS (LAL)$317
- Hydrus Microstent$150
- OZURDEX$134
- Tecnis Simplicity$123
- CATALYS SYSTEM$123
- VERITAS Vision System$123
- iDose$121
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$121
- Humira$120
- STELLARIS PC$119
How this compares
$10,390 in reported general payments places this provider in the 95th percentile of 248 ophthalmology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 293 | $9,824 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 18 | $3,187 |
| Brimonidine Tartrate | 137 | $3,128 |
| Latanoprost | 369 | $2,903 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 121 | $1,808 |
| Ofloxacin | 121 | $1,580 |
| Timolol Maleate | 114 | $1,207 |
| Dorzolamide Hcl | 19 | $368 |
| Acyclovir | 18 | $242 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 18 | $229 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Eugene
- Balamurali AmbatiEugene$19K
- Richard HoffmanEugene$17K
- Justin EtzelEugene$6K
- Jason GrossEugene$6K
- John HainesEugene$6K
- Joseph MandoEugene$4K
- Shelley JelineoEugene$4K
- Robert BeardsleyEugene$4K
- Kent KarrenEugene$4K
- Brian WalkerEugene$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.